Gaxos.AI Surpasses Forecasts with Strong Q4 Performance, Raises Revenue Forecast to $7M

Gaxos.AI reported Q4 2025 revenue of $1.2 million, up from $1,300 in the year-ago period, with both RNK Health and Gaxos Labs beating estimates. The company raised its revenue forecast for the year to $7 million. However, operating expenses increased to $2.5 million, up from $900,000 a year ago, primarily due to advertising spending. The net loss per share declined to $0.55 from $1.92, but the operating loss increased to $4.9 million, up from $3.7 million in 2024.